MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway

In previous studies, miR-29s showed tumor suppressor properties against lung cancer, which improved the survival of patients upon the administration of chemotherapy via an unknown mechanism. Here, we investigated the regulatory effects of miR-29s on the cisplatin resistance of NSCLC cells. The expre...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Dian-min, Tang, Bu-fu, Li, Zhen-xiang, Guo, Hong-bo, Cheng, Jin-ling, Song, Ping-ping, Zhao, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964122/
https://www.ncbi.nlm.nih.gov/pubmed/29789623
http://dx.doi.org/10.1038/s41598-018-26381-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964122/
https://www.ncbi.nlm.nih.gov/pubmed/29789623
http://dx.doi.org/10.1038/s41598-018-26381-w

Ejemplares similares